Construction of a cytomegalovirus-based amplicon: A vector with a unique transfer capacity

Human Gene Therapy

Volumn 14, Issue 10, 2003, Pages 959-970

  Borst, Eva Maria ^a   Messerle, Martin ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; VIRUS VECTOR;

AMPLICON; ARTICLE; CONTROLLED STUDY; DNA ISOLATION; DNA PACKAGING; DNA VECTOR; GENE DELIVERY SYSTEM; GENE SEQUENCE; GENE TRANSFER; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MOLECULAR WEIGHT; TRANSGENE; VIRUS CAPSID; VIRUS GENOME; VIRUS REPLICATION;

CAPSID; CELLS, CULTURED; CHROMOSOMES, ARTIFICIAL, P1 BACTERIOPHAGE; CYTOMEGALOVIRUS; FIBROBLASTS; GENETIC VECTORS; GENOME, VIRAL; GREEN FLUORESCENT PROTEINS; HELPER VIRUSES; HUMANS; LUMINESCENT PROTEINS; PLASMIDS; REPLICATION ORIGIN; TRANSDUCTION, GENETIC; VIRUS ASSEMBLY; VIRUS REPLICATION;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0037560207     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403766682223     Document Type: Article

References (63)

1. ANDERS, D.G., KACICA, M.A., PARI, G., and PUNTURIERI, S.M. (1992). Boundaries and structure of human cytomegalovirus oriLyt, a complex origin for lytic-phase DNA replication. J. Virol. 66, 3373-3384.
2. BERGER, C., XUEREB, S., JOHNSON, D.C., WATANABE, K.S., KIEM, H.P., GREENBERG, P.D., and RIDDELL, S.R. (2000). Expression of herpes simplex virus ICP47 and human cytomegalovirus US11 prevents recognition of transgene products by CD8(+) cytotoxic T lymphocytes. J. Virol. 74, 4465-4473.
3. BHELLA, D., RIXON, F.J., and DARGAN, D.J. (2000). Cryomicroscopy of human cytomegalovirus virions reveals more densely packed genomic DNA than in herpes simplex virus type 1. J. Mol. Biol. 295, 155-161.
4. BODNAR, A.G., OUELLETTE, M., FROLKIS, M., HOLT, S.E., CHIU, C.P., MORIN, G.B., HARLEY, C.B., SHAY, J.W., LICHTSTEINER, S., and WRIGHT, W.E. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352.
5. BORST, E.M., HAHN, G., KOSZINOWSKI, U.H., and MESSERLE, M. (1999). Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: A new approach for construction of HCMV mutants. J. Virol. 73, 8320-8329.
6. BORST, E.M., MATHYS, S., WAGNER, M., MURANYI, W., and MESSERLE, M. (2001). Generic evidence of an essential role for cytomegalovirus small capsid protein in viral growth. J. Virol. 75, 1450-1458.
7. BRESNAHAN, W.A., HULTMAN, G.E., and SHENK, T. (2000). Replication of wild-type and mutant human cytomegalovirus in life-extended human diploid fibroblasts. J. Virol. 74, 10816-10818.
8. BRITT, W.J. and ALFORD, C.A. (1996). Cytomegalovirus. In Fields Virology. B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (Lippincott-Raven Publishers, Philadelphia, PA) pp. 2493-2524.
9. BRUNE, W., MENARD, C., HOBOM, U., ODENBREIT, S., MESSERLE, M., and KOSZINOWSKI, U.H. (1999). Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis. Nat. Biotechnol. 17, 360-364.
10. BRUNE, W., MESSERLE, M., and KOSZINOWSKI, U.H. (2000). Forward with BACs: New tools for herpesvirus genomics. Trends Genet. 16, 254-259.
11. BUTCHER, S.J., AITKEN, J., MITCHELL, J., GOWEN, B., and DARGAN, D.J. (1998). Structure of the human cytomegalovirus B capsid by electron cryomicroscopy and image reconstruction. J. Struct. Biol. 124, 70-76.
12. CAREW, J.F., KOOBY, D.A., HALTERMAN, M.W., KIM, S.H., FEDEROFF, H.J., and FONG, Y. (2001). A novel approach to cancer therapy using an oncolytic herpes virus to package amplicons containing cytokine genes. Mol. Ther. 4, 250-256.
13. CHEE, M.S., BANKIER, A.T., BECK, S., BOHNI, R., BROWN, C.M., CERNY, R., HORSNELL, T., HUTCHISON, C.A., KOUZARIDES, T., MARTIGNETTI, J.A., PREDDIE, E., SATCHWELL, S.C., TOMLINSON, P., WESTON, K.M., and BARRELL, B.G. (1990). Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154, 125-169.
14. COTTER, M.A., and ROBERTSON, E.S. (1999). Molecular genetic analysis of herpesviruses and their potential use as vectors for gene therapy applications. Curt. Opin. Mol. Ther. 1, 633-644.
15. DELECLUSE, H.J., PICH, D., HILSENDEGEN, T., BAUM, C., and HAMMERSCHMIDT, W. (1999). A first-generation packaging cell line for Epstein-Barr virus-derived vectors. Proc. Natl. Acad. Sci. U.S.A. 96, 5188-5193.
16. DORSCH-HASLER, K., KEIL, G.M., WEBER, F., JASIN, M., SCHAFFNER, W., and KOSZINOWSKI, U.H. (1985). A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc. Natl. Acad. Sci. U.S.A. 82, 8325-8329.
17. FLECKENSTEIN, B., MULLER, I., and COLLINS, J. (1982). Cloning of the complete human cytomegalovirus genome in cosmids. Gene 18, 39-46.
18. FRAEFEL, C., JACOBY, D.R., and BREAKEFIELD, X.O. (2000). Herpes simplex virus type 1-based amplicon vector systems. Adv. Virus Res. 55, 425-451.
19. FRAEFEL, C., SONG, S., LIM, F., LANG, P., YU, L., WANG, Y., WILD, P., and GELLER, A.I. (1996). Helper virus-tree transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol. 70, 7190-7197.
20. GLORIOSO, J.C., DELUCA, N.A., and FINK, D.J. (1995). Development and application of herpes simplex virus vectors for human gene therapy. Annu. Rev. Microbiol. 49, 675-710.
21. HAHN, G., JORES, R., and MOCARSKI, E.S. (1998). Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. U.S.A. 95, 3937-3942.
22. HAMMERSCHMIDT, W. (2000). Herpesvirus vector come of age. Curr. Opin. Mol. Ther. 2, 532-539.
23. HIRT, B. (1967). Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365-369.
24. JACOBS, A., BREAKEFIELD, X.O., and FRAEFEL, C. (1999). HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications. Neoplasia 1, 402-416.
25. JOHNSTON, K.M., JACOBY, D., PECHAN, P.A., FRAEFEL, C., BORGHESANI, P., SCHUBACK, D., DUNN, R.J., SMITH, F.I., and BREAKEFIELD, X.O. (1997). HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum. Gene Ther. 8, 359-370.
26. JOOSS, K., ERTL, H.C., and WILSON, J.M. (1998). Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver. J. Virol. 72, 2945-2954.
27. KELLEHER, Z.T., FU, H., LIVANOS, E., WENDELBURG, B., GULINO, S., and VOS, J.M. (1998). Epstein-Barr-based episomal chromosomes shuttle 100 kb of self-replicating circular human DNA in mouse cells. Nat. Biotechnol. 16, 762-768.
28. KOMAKI, S. and VOS, J.M. (2000). Epstein-Barr virus vectors for gene therapy. Adv. Virus Res. 55, 453-462.
29. LOENEN, W.A., BRUGGEMAN, C.A., and WIERTZ, E.J. (2001). Immune evasion by human cytomegalovirus: Lessons in immunology and cell biology. Semin. Immunol. 13, 41-49.
30. LUTZKO, C., KRUTH, S., ABRAMS-OGG, A.C., LAU, K., LI, L., CLARK, BR., RUEDY, C., NANJI, S., FOSTER, R., KOHN, D., SHULL, R., and DUBE, I.D. (1999). Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine alpha-L-iduronidase deficiency. Blood 93, 1895-1905.
31. MACIEJEWSKI, J.P. and ST JEOR, S.C. (1999). Human cytomegalovirus infection of human hematopoietic progenitor cells. Leuk. Lymphoma 33, 1-13.
32. MAGUIR-ZEIS, K.A., BOWERS, W.J., and FEDEROFF, H.J. (2001). HSV vector-mediated gene delivery to the central nervous system. Curr. Opin. Mol. Ther. 3, 482-490.
33. MARSH, D.R., DEKABAN, G.A., TAN, W., STRATHDEE, C.A., and WEAVER, L.C. (2000). Herpes simplex viral and amplicon vector-mediated gene transfer into glia and neurons in organotypic spinal cord and dorsal root ganglion cultures. Mol. Ther. 1, 464-478.
34. MASSE, M.J., KARLIN, S., SCHACHTEL, G.A., and MOCARSKI, E.S. (1992). Human cytomegalovirus origin of DNA replication (oriLyt) resides within a highly complex repetitive region. Proc. Natl. Acad. Sci. U.S.A. 89, 5246-5250.
35. MASSE, M.J., MESSERLE, M., and MOCARSKI, E.S. (1997). The location and sequence composition of the marine cytomegalovirus replicator (oriLyt). Virology 230, 350-360.
36. MCSHARRY, B.P., JONES, C.J., SKINNER, J.W., KIPLING, D., and WILKINSON, G.W. (2001). Human telomerase reverse transcriptase-immortalized MRC-5 and HCA2 human fibroblasts are fully permissive for human cytomegalovirus. J. Gen. Virol. 82, 855-863.
37. MESSERLE, M., CRNKOVIC, I., HAMMERSCHMIDT, W., ZIEGLER, H., and KOSZINOWSKI, U.H. (1997). Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. U.S.A. 94, 14759-14763.
38. MOCARSKI, E.S. (1996). Cytomegaloviruses and their replication. In Fields Virology. B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (Lippincott-Raven Publishers, Philadelphia, PA) pp. 2447-2492.
39. MOVASSAGH, M., GOZLAN, J., SENECHAL, B., BAILLOU, C., PETIT, J.C., and LEMOINE, F.M. (1996). Direct infection of CD34+ progenitor cells by human cytomegalovirus: Evidence for inhibition of hematopoiesis and viral replication. Blood 88, 1277-1283.
40. RAWLINSON, W.D., FARRELL, H.E., and BARRELL, B.G. (1996). Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70, 8833-8849.
41. RIDDELL, S.R., ELLIOTT, M., LEWINSOHN, D.A., GILBERT, M.J., WILSON, L., MANLEY, S.A., LUPTON, S.D., OVERELL, R.W., REYNOLDS, T.C., COREY, L., and GREENBERG, P.D. (1996). T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat. Med. 2, 216-223.
42. ROIZMAN, B. (1996). The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors. Proc. Natl. Acad. Sci. U.S.A. 93, 11307-11312.
43. ROIZMAN, B. and SEARS, A.E. (1996). Herpes simplex viruses and their replication. In Fields Virology. B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (Lippincott-Raven Publisher, Philadelphia, PA) pp. 2231-2295.
44. ROMI, H., SINGER, O., RAPAPORT, D., and FRENKEL, N. (1999). Tamplicon-7, a novel T-lymphotropic vector derived from human herpesvirus 7. J. Virol. 73, 7001-7007.
45. SAEKI, Y., FRAEFEL, C., ICHIKAWA, T., BREAKEFIELD, X.O., and CHIOCCA, E.A. (2001). Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol. Ther. 3, 591-601.
46. SAEKI, Y., ICHIKAWA, T., SAEKI, A., CHIOCCA, E.A., TOBLER, K., ACKERMANN, M., BREAKEFIELD, X.O., and FRAEFEL, C. (1998). Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: Rescue of replication-competent vires progeny and packaging of amplicon vectors. Hum. Gene. Ther. 9, 2787-2794.
47. SENA-ESTEVES, M., SAEKI, Y., CAMP, S.M., CHIOCCA, E.A., and BREAKEFIELD, X.O. (1999). Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons. J. Virol. 73, 10426-10439.
48. SENA-ESTEVES, M., SAEKI, Y., FRAEFEL, C., and BREAKEFIELD, X.O. (2000). HSV-1 amplicon vectors - Simplicity and versatility. Mol. Ther. 2, 9-15.
49. SODERBERG-NAUCLER, C., FISH, K.N., and NELSON, J.A. (1997). Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91, 119-126.
50. SOMIA, N. and VERMA, I.M. (2000). Gene therapy: Trials and tribulations. Nat. Rev. Genet. 1, 91-99.
51. SPAETE, R.R., and FRENKEL, N. (1982). The herpes simplex vires amplicon: A new eucaryotic defective-virus cloning-amplifying vector. Cell 30, 295-304.
52. SPAETE, R.R., and FRENKEL, N. (1985). The herpes simplex virus amplicon: Analyses of cis-acting replication functions. Proc. Natl. Acad. Sci. U.S.A. 82, 694-698.
53. SPAETE, R.R., and MOCARSKI, E.S. (1985). The alpha sequence of the cytomegalovirus genome functions as a cleavage/packaging signal for herpes simplex virus defective genomes. J. Virol. 54, 817-824.
54. STOW, N.D., and MCMONAGLE, E.C. (1983). Characterization of the TRS/IRS origin of DNA replication of herpes simplex virus type 1. Virology 130, 427-438.
55. TAMASHIRO, J.C., FILPULA, D., FRIEDMANN, T., and SPECTOR, D.H. (1984). Structure of the heterogeneous L-S junction region of human cytomegalovirus strain AD169 DNA. J. Virol. 52, 541-548.
56. TOLBA, K.A., BOWERS, W.J., HILCHEY, S.P., HALTERMAN, M.W., HOWARD, D.F., GIULIANO, R.E., FEDEROFF, H.J., and ROSENBLATT, J.D. (2001). Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia. Blood 98, 287-295.
57. WADE-MARTINS, R., SMITH, E.R., TYMINSKI, E., CHIOCCA, E.A., and SAEKI, Y. (2001). An infectious transfer and expression system for genomic DNA loci in human and mouse cells. Nat. Biotechnol. 19, 1067-1070.
58. WAGNER, M., JONJIC, S., KOSZINOWSKI, U.H., and MESSERLE, M. (1999). Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73, 7056-7060.
59. WANG, Y., MUKHERJEE, S., FRAEFEL, C., BREAKEFIELD, X.O., and ALLEN, P.D. (2002). Herpes simplex virus type 1 amplicon vector-mediated gene transfer to muscle. Hum. Gene Ther. 13, 261-273.
60. WELLER, S.K., SPADARO, A., SCHAFFER, J.E., MURRAY, A.W., MAXAM, A.M., and SCHAFFER, P.A. (1985). Cloning, sequencing, and functional analysis of oriL, a herpes simplex virus type 1 origin of DNA synthesis. Mol. Cell Biol. 5, 930-942.
61. WU, X., LEDUC, Y., CYNADER, M., and TUFARO, F. (1995). Examination of conditions affecting the efficiency of HSV-1 amplicon packaging. J. Virol. Methods 52, 219-229.
62. ZHENG, C., BAUM, B.J., IADAROLA, M.J., and O'CONNELL, B.C. (2000). Genomic integration and gene expression by a modified adenoviral vector. Nat. Biotechnol. 18, 176-180.
63. ZHU, Y., HUANG, L., and ANDERS, D.G. (1998). Human cytomegalovirus oriLyt sequence requirements. J. Virol. 72, 4989-4996.